Abstract:OBJECTIVE To test the possibility of using bone marrow stromal cells (BMSC) and biodegradable polymers to repair articular osteochondral defects at non-weight bearing area of porcine knee joints. METHODS Bone marrows were harvested from 18 hybrid pigs. BMSC were cultured and in vitro expanded and induced with dexamethasone (group A) or with dexamethasone and transforming growth factor-beta1 (TGF-beta1) (group B) respectively. Immunohistochemistry and RT-PCR were used to evaluate chondrogenic differentiation of induced cells. Part of BMSC of 2 animals were retrovirally-labeled with green fluorescent protein (GFP). After induction and label, cells were seeded on a construct of polyglycolic acid (PGA) and polylactic acid (PLA) and co-cultured for 1 week before implantation. Total 4 osteochondral defects (8 mm in diameter, 5 mm in depth) in each animal were created at the non-weight bearing areas of knee joints on both sides. The defects were repaired with dexamethasone induced BMSC-PGA/PLA construct in group A, with dexamethasone and TGF-beta1 induced BMSC-PGA/PLA construct in group B, with PGA/PLA construct alone (group C) or left untreated (group D) as controls. Animals were sacrificed at 3 months (n = 6) or 6 months (n = 10) post-repair. Gross observation, histology, glycosaminoglycan (GAG) quantification and biomechanical test were applied to analyze the results. The two animals with GFP-labeled cells were sacrificed at 7 months post-repair to observe with confocal microscope the distribution of GFP-labeled cells in repaired tissue. RESULTS Stronger expression of type II collagen and aggrecan were observed in BMSCs induced with both dexamethasone and TGF-beta1. At both time points, Gross observation and histology showed that the defects in most of group A were repaired by engineered fibrocartilage and cancellous bone with an irregular surface, minority defects were repaired by engineered hyaline cartilage and cancellous bone. However, in most of group B, the defects were completely repaired by engineered hyaline cartilage and cancellous bone. No repair or only fibrous tissue were observed in groups C and D. Besides, the compressive moduli of repaired cartilage in groups A and B reached 30.37% and 43.82% of normal amount at 3 months and 62.69% and 80.27% at 6 months respectively, which was further supported by the high levels of GAG contents in engineered cartilage of group A (78.03% of normal contents) and group B (no statistical difference from normal contents). More importantly, confocal microscope revealed the presence of GFP-labeled cells in engineered cartilage lacuna and repaired underlying cancellous bone. CONCLUSION The results demonstrated that implanted BMSC can differentiate into either chondrocytes or osteoblasts at different local environments and repair a complex articular defect with both engineered cartilage and bone. TGF-beta1 and dexamethasone in vitro induction can promote chondrogenic differentiation of BMSC and thus improve the results of repairing articular defects.

Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model

Osteochondral repair using porous poly(lactide-co-glycolide)/nano-hydroxyapatite hybrid scaffolds with undifferentiated mesenchymal stem cells in a rat model.

Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells

Repair of large articular cartilage defects with implants of autologous mesenchymal stem cells seeded into β-tricalcium phosphate in a sheep model

One-step Strategy for Cartilage Repair Using Acellular Bone Matrix Scaffold Based in Situ Tissue Engineering Technique in a Preclinical Minipig Model.

Acellular cartilage matrix biomimetic scaffold with immediate enrichment of autologous bone marrow mononuclear cells to repair articular cartilage defects

Repair of Articular Cartilage Defects with Acellular Cartilage Sheets in a Swine Model

In Situ Cartilage Regeneration with Acellular Bone Matrix in a Preclinical Model

Repair of Osteochondral Defects with Rehydrated Freeze-Dried Oligo[Poly(Ethylene Glycol) Fumarate] Hydrogels Seeded with Bone Marrow Mesenchymal Stem Cells in a Porcine Model

Repairing large porcine full-thickness defects of articular cartilage using autologous chondrocyte-engineered cartilage.

Repair of osteochondral defects mediated by double-layer scaffolds with natural osteochondral-biomimetic microenvironment and interface

[Repairing Porcine Knee Joint Osteochondral Defects at Non-Weight Bearing Area by Autologous BMSC].

A Xenogeneic Decellularized Multiphasic Scaffold for the Repair of Osteochondral Defects in a Rabbit Model

Animal-origin osteochondral scaffold combined with bone marrow mesenchymal stem cells/chondrocytes for repair of composite osteochondral defects in rabbit knee joints

In Situ Articular Cartilage Regeneration Through Endogenous Reparative Cell Homing Using a Functional Bone Marrow-Specific Scaffolding System

Combined Effects of Connective Tissue Growth Factor-Modified Bone Marrow-Derived Mesenchymal Stem Cells and Naoh-Treated Plga Scaffolds on the Repair of Articular Cartilage Defect in Rabbits

Regenerated silk fibroin based on small aperture scaffolds and marginal sealing hydrogel for osteochondral defect repair

Osteogenesis and Chondrogenesis of Biomimetic Integrated Porous Pva/Gel/V-N-Ha/Pa6 Scaffolds and Bmscs Construct in Repair of Articular Osteochondral Defect

In Vitro Cartilage Production Using an Extracellular Matrix-Derived Scaffold and Bone Marrow-Derived Mesenchymal Stem Cells.

Repair of Large Articular High-Load-bearing Osteochondral Defects in Canine Hip Joint Using Tissue-Engineered Osteochondral Constructs

Biomimetic Design and Fabrication of Multilayered Osteochondral Scaffolds by Low-Temperature Deposition Manufacturing and Thermal-Induced Phase-Separation Techniques